维普中文期刊产品整合服务
86篇 您的检索式:作者名="Egorin"
    题名 作者 年代 出处 被引量
1Effect of a proton pump inhibitor on the pharmacokinetics of imatinib显示文摘Egorin M Shah D Christner S 2009British Journal of Clinical Pharmacology2009,68,3:1
2Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17 -demethoxygeldanamycin(NSC 330507)in CK 2F1 micel显示文摘Egorin MJ Zuhowski EG Rosen DM 2001Cancer Chemother Pharmacol2001,47,4:1
3Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry显示文摘Kosovec J E Egorin M J Gjurich S 2008Rapid Commun Mass Spectrom2008,22,2:1
4Effect of antacid on imatinib absorption显示文摘Sparano BA Egorin MJ Parise RA 2009Cancer Chemother Pharmacol2009,63,3:1
5Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin(NSC 330507)and metabolites by Fischer 344 rats显示文摘Musser SM Egorin MJ 2003Cancer Chemother Pharmacol2003,52,2:1
6Relationship between carboplatin exposure and tumour response and toxicity in patients with ovarian cancer显示文摘Jodrell DI Egorin MJ Canetta RM 1992J Clin Oncol1992,10,:1
7Colloid-stable nanosized selective sorbents for decontamination of bulk materials显示文摘Avramenko V A Bratskaya S Y Egorin A M 2008Doklandy Chem2008,422,5:1
8A phase Ⅰ study of 171allylamino 17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies显示文摘Ramalingam S S Egorin M J Ramanathan R K 2008Clin Cancer Res2008,14,11:1
9Pharmacokinetics of intrathecal gencitabine in nonhuman primates显示文摘 Zuhowski EG McCully CM 2002Clin Cancer Res2002,8,7:1
10Phase Ⅰ and pharmacologic study of intermittently administered 9- nitrocamptothecin in patients with advanced solid tumors显示文摘ZAMBONI WC JUNG LL EGORIN MJ 2004Clin Cancer Res2004,10,15:1
11Cancer pharmarcology in the elderly显示文摘Egorin MJ 1993Semin Oncology1993,20,1:1
12Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors显示文摘JUNG LL RAMANATHAN RK EGORIN MJ 2004Cancer Chemother Pharmacol2004,54,6:1
13Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance显示文摘Elizabeth R. Glaze Amy L. Lambert Adaline C. Smith John G. Page William D. Johnson David L. McCormick Alan P. Brown Barry S. Levine Joseph M. Covey Merrill J. Egorin Julie L. Eiseman Julianne L. Holleran Edward A. Sausville Joseph E. Tomaszewski 2005Cancer Chemotherapy and Pharmacology2005,,6:1
14Cancer pharmacology in the ehterly 显示文摘Egorin MJ 1993Semin Oneol1993,20,1:1
15Cancer pharmacotogy in the elderly 显示文摘Egorin MJ 1993Semin Oncol1993,20,1:1
16Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers显示文摘Ramanathan R K Egorin M J Eiseman J L 2007Clin Cancer Res2007,13,6:1
17Relationships be- tween carboplatin exposure and tumor response and toxicity in patients with ovarian cancer显示文摘Jodrell DI Egorin MJ Canetta RM 1992J Clinical Oncol1992,10,4:1
18Phase Ⅰ and pharmacokinetics trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565显示文摘 Egorin MJ Rosner GL 2000J Clin Oncol2000,18,14:1
19Relationshipsbetween carboplatin exposure and tumor response and tox-icity in patients with ovarian cancer显示文摘Jodrell DI Egorin MJ Canetta RM 1992J Clin Oncol1992,10,4:1
20Systemic and tumor disposition of platinum after administration of cisplatin or stealth liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma 显示文摘ZAMBONI WC GERVAIS AC EGORIN MJ 2004Cancer Chemother Pharmacol2004,53,4:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费